Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Red Grape

What does the research say about Red Grape?

14 health outcomes synthesised

Research on red grape extract (primarily grape seed extract) has investigated 14 health outcomes, with the strongest evidence supporting a reduction in diastolic blood pressure. Across 6 studies, including meta-analyses and RCTs, the evidence is rated high and shows a small beneficial effect, with a typical dose of 520 mg/day used in one trial. The most responsive populations appear to be people with hypertension, metabolic syndrome, or NAFLD, though the evidence base is limited by small sample sizes and short study durations.

Strongest evidence

Red grape extract (mostly grape seed extract) shows moderate-to-high evidence for several cardiovascular and metabolic outcomes. The strongest evidence is for reduced diastolic blood pressure (high evidence; 5 of 6 studies beneficial, small effect, dose 520 mg/day in one RCT). Other outcomes with moderate evidence include:

  • Reduced systolic blood pressure (4 of 6 studies beneficial, doses 300–520 mg/day)
  • Reduced mean arterial pressure (5 of 5 studies beneficial, single dose 300 mg or 520 mg/day)
  • Reduced triglycerides (4 of 4 studies beneficial, doses 300–520 mg/day)
  • Reduced AST and ALT (liver enzymes; 3 of 4 and 2 of 3 studies beneficial, doses 100–520 mg/day)
  • Improved insulin sensitivity and insulin levels (3 of 3 studies beneficial, doses 100–520 mg/day)
  • Reduced blood cholesterol (3 of 3 studies beneficial, dose 520 mg/day in one RCT)

Mixed or weaker evidence

Three outcomes have low evidence strength:

  • Reduced heart rate (1 of 4 studies beneficial, meta-analysis showed a small effect but individual RCTs neutral)
  • Reduced LDL cholesterol (3 of 3 studies beneficial, but all small, effect size small, and clinical significance uncertain)
  • Reduced body weight (1 of 3 studies beneficial, 2 neutral; effect small and inconsistent)

Effective dose patterns

Across multiple outcomes, effective doses of grape seed extract cluster in the 300–520 mg/day range. Some studies also used 100 mg/day, particularly in adolescents with metabolic syndrome. Doses were often taken for 4–12 weeks, with median study durations around 34–72 days depending on the outcome.

Population insights

Most research was conducted in clinical populations: people with non‑alcoholic fatty liver disease (NAFLD), hypertension or prehypertension, metabolic syndrome, and obese/overweight individuals. A few studies included adolescents or men specifically. Generalizability to healthy individuals is unclear.

Notable caveats

  • Publication bias is a concern: null results are less likely to be published, so the positive signal may be exaggerated.
  • Sample sizes are small (often 9–25 participants), and study durations are short (mostly 7–60 days).
  • Nearly all studies used grape seed extract, not whole red grape, juice, or other forms; findings may not apply to other preparations.
  • Dose reporting was inconsistent, and many studies did not specify the exact formulation or polyphenol content.
  • Most evidence comes from specific clinical populations; benefits in healthy individuals are not well studied.

Frequently asked

  • What is Red Grape good for according to research?
    The strongest evidence supports a small reduction in diastolic blood pressure (5 of 6 studies, high evidence). Moderate evidence also suggests benefits for systolic blood pressure, mean arterial pressure, triglycerides, liver enzymes (AST/ALT), insulin sensitivity, and total cholesterol. Most studies used grape seed extract rather than whole red grape.
  • What dose of Red Grape is typically used in studies?
    Across multiple outcomes, effective doses of grape seed extract range from 100–520 mg/day, with the most common range being 300–520 mg/day. One RCT used 520 mg/day for blood pressure reduction. Doses were taken for 4–12 weeks, though study durations varied.
  • Who benefits most from Red Grape?
    Research primarily involved clinical populations: people with hypertension, prehypertension, non‑alcoholic fatty liver disease (NAFLD), metabolic syndrome, and obesity. Effects were observed in these groups, but generalizability to healthy individuals is uncertain due to small sample sizes and narrow study populations.
  • Are there caveats or limitations in the research on Red Grape?
    Yes. The evidence is subject to publication bias (null results are less likely published), most studies had small sample sizes (9–25 participants), and durations were short (7–60 days). Nearly all studies used grape seed extract, not whole red grape, so findings may not apply to other forms. Additionally, dose reporting was inconsistent.
  • Does Red Grape help with blood pressure?
    Research suggests a small beneficial effect on diastolic blood pressure (high evidence, 5 of 6 studies) and systolic blood pressure (moderate evidence, 4 of 6 studies). The effect appears more consistent in people with hypertension or metabolic syndrome, with doses around 300–520 mg/day of grape seed extract over 4–8 weeks.
  • Does Red Grape improve insulin sensitivity?
    Moderate evidence from 3 studies (all beneficial) shows that grape seed extract at doses of 100–520 mg/day can improve insulin sensitivity markers (HOMA-IR, QUICKI) in patients with NAFLD or metabolic syndrome. Effects were observed over 8–12 weeks, but the evidence base is small and preliminary.

Most-studied combinations with Red Grape

most supplement research is combination research
Also studied with:Turmeric (2), Ginkgo (2), Thistle (2)
    Back to top